Nur Rahman Ahmad Seno Aji | Medicine and Dentistry | Research Excellence Award

Published on by Global Scholar Awards

Mr. Nur Rahman Ahmad Seno Aji | Medicine and Dentistry | Research Excellence Award

Doctoral Researcher | Universitas Gadjah Mada | Finland

Dr. Nur Rahman Ahmad Seno Aji is a distinguished academic and clinical researcher specializing in periodontology, periodontal medicine, geriatric periodontology, and host modulation therapy. As a staff member in the Department of Periodontics at Universitas Gadjah Mada, he has contributed extensively to translational oral healthcare research through innovative studies on biomarker diagnostics, regenerative therapies, and periodontal disease management. His scientific work focuses on active matrix metalloproteinase-8 (aMMP-8), periodontal inflammation, aging periodontal tissues, and oral-systemic disease relationships. Dr. Aji has established strong international research collaborations with scholars from Finland, Greece, and the United Kingdom, resulting in impactful publications in internationally reputed journals. His research contributions have strengthened evidence-based dentistry and advanced precision periodontal diagnostics. Alongside his academic achievements, he actively participates in mentoring, healthcare outreach, and interdisciplinary scientific collaboration, demonstrating commitment to improving global oral healthcare standards and advancing modern periodontal medicine through innovative clinical and translational research approaches.

Professional Profile 

Education

Dr. Nur Rahman Ahmad Seno Aji possesses advanced academic and professional qualifications in dentistry and periodontal medicine. He earned his Doctor of Dental Surgery degree before pursuing postgraduate specialization in Periodontics, followed by MDSc qualifications and subspecialty expertise in Periodontal Medicine. His educational background reflects strong interdisciplinary scientific training integrating clinical dentistry, molecular diagnostics, regenerative biomaterials, and translational healthcare research. Through his academic progression at Universitas Gadjah Mada, he developed specialized expertise in geriatric periodontology, periodontal diagnostics, host modulation therapy, and evidence-based oral healthcare practices. His academic foundation enabled him to participate in international collaborative research involving biomarker diagnostics and periodontal disease monitoring. Continuous scientific learning and advanced clinical training have contributed significantly to his ability to conduct innovative research in periodontal regeneration, molecular biomarkers, and personalized treatment strategies. His qualifications demonstrate a strong commitment to academic excellence, professional development, and advancing modern periodontal healthcare sciences internationally.

Professional Experience

Dr. Nur Rahman Ahmad Seno Aji serves as a faculty member in the Department of Periodontics at Universitas Gadjah Mada, where he contributes to teaching, research, clinical supervision, and interdisciplinary healthcare initiatives. His professional experience includes mentoring dental students, supporting evidence-based periodontal care, and participating in international collaborative projects related to periodontal diagnostics and oral-systemic health. He has demonstrated leadership through involvement in healthcare outreach programs, institutional academic development, and scientific research activities. His work emphasizes the integration of clinical practice with translational biomedical research, particularly in biomarker diagnostics and regenerative periodontal therapies. Dr. Aji has collaborated with researchers and clinicians from multiple countries, contributing to innovative scientific advancements in periodontal medicine. His experience in academic leadership, clinical periodontology, and collaborative healthcare research has strengthened his reputation as a dedicated educator and researcher committed to improving oral healthcare standards and promoting innovative evidence-based dental practices globally.

Research Interest

Dr. Nur Rahman Ahmad Seno Aji has broad research interests centered on periodontal medicine, aging periodontal tissues, host modulation therapy, geriatric periodontology, and biomarker diagnostics. His work particularly focuses on active matrix metalloproteinase-8 (aMMP-8) as a diagnostic biomarker for periodontal and peri-implant diseases. He is also interested in regenerative periodontal therapies involving platelet-rich fibrin, nanofiber membranes, and innovative biomaterials for tissue healing and periodontal regeneration. His studies explore oral-systemic disease relationships, including links between periodontitis, diabetes, cancer, and systemic inflammation. Additionally, he conducts research on artificial intelligence-assisted radiographic analysis for periodontitis detection and evidence-based clinical applications in dentistry. His multidisciplinary scientific interests integrate molecular biology, regenerative medicine, biomedical diagnostics, and clinical periodontology. Through collaborative international research projects, Dr. Aji aims to develop advanced diagnostic technologies and personalized treatment strategies that improve patient outcomes and contribute to modern precision dentistry and translational oral healthcare sciences worldwide.

Award and Honor

Dr. Nur Rahman Ahmad Seno Aji has gained significant academic recognition through his impactful scientific contributions, international collaborations, and growing research visibility in periodontal medicine. His publications in internationally reputed journals such as Biomedicines, Diagnostics, International Journal of Molecular Sciences, and European Journal of Dentistry have earned strong citation impact and academic acknowledgment within the global dental research community. With 131 citations, 15 Scopus-indexed publications, and an h-index of 6, he has established a promising scientific profile in translational periodontal research. His collaborative studies involving researchers from Europe and Asia demonstrate international scientific credibility and professional recognition. Dr. Aji’s contributions to biomarker diagnostics, regenerative periodontal therapy, and oral-systemic disease research have strengthened evidence-based dentistry and modern periodontal healthcare practices. His achievements reflect dedication to research excellence, innovation, academic leadership, and the advancement of global oral healthcare through high-quality scientific investigation and interdisciplinary collaboration.

Conclusion

Dr. Nur Rahman Ahmad Seno Aji is an emerging leader in periodontal medicine and translational oral healthcare research. His expertise in biomarker diagnostics, regenerative therapies, and evidence-based dentistry has contributed significantly to modern periodontal science. Through international collaborations, impactful publications, and dedication to academic and clinical excellence, he demonstrates strong potential for continued leadership and global recognition in periodontal and regenerative dental research.

Publications Top Noted

  • Comparison of Multi-Label U-Net and Mask R-CNN for Panoramic Radiograph Segmentation to Detect Periodontitis
    Authors: R Widyaningrum, I Candradewi, NRAS Aji, R Aulianisa
    Year: 2022
    Citation: Imaging Science in Dentistry 52(4), 383
  • Active Matrix Metalloproteinase-8 (aMMP-8) versus Total MMP-8 in Periodontal and Peri-Implant Disease Point-of-Care Diagnostics
    Authors: IT Räisänen, NRAS Aji, D Sakellari, A Grigoriadis, I Rantala, et al.
    Year: 2023
    Citation: Biomedicines 11(11), 2885
  • In Vivo Regulation of Active Matrix Metalloproteinase-8 (aMMP-8) in Periodontitis: From Transcriptomics to Real-Time Online Diagnostics and Treatment Monitoring
    Authors: NRAS Aji, T Yucel-Lindberg, IT Räisänen, H Kuula, MT Nieminen, et al.
    Year: 2024
    Citation: Diagnostics 14(10), 1011
  • aMMP-8 POCT vs. Other Potential Biomarkers in Chair-Side Diagnostics and Treatment Monitoring of Severe Periodontitis
    Authors: NRAS Aji, IT Räisänen, N Rathnayake, FT Lundy, MTC Mc Crudden, et al.
    Year: 2024
    Citation: International Journal of Molecular Sciences 25(17), 9421
  • Prediabetes Associates with Matrix Metalloproteinase-8 Activation and Contributes to the Rapid Destruction of Periodontal Tissues
    Authors: KA Umeizudike, NRAS Aji, K Niskanen, I Rantala, D Sakellari, et al.
    Year: 2025
    Citation: European Journal of Dentistry 19(02), 305-314
  • Oral Medicine and Oral Clinical Chemistry Game Changers for Future Plaque Control and Maintenance: PerioSafe® aMMP-8 POCT, Lumoral® 2× PDT-and Lingora® Fermented Lingonberry
    Authors: NRAS Aji, V Sahni, MT Penttala, D Sakellari, A Grigoriadis, et al.
    Year: 2025
    Citation: Dentistry Journal 13(3), 127
  • Evaluation of Bio-Compatibility and Effectiveness of Propolis Tetragonula sp. as Dental Anti-Microbial Agent
    Authors: A Adiningrat, I Maulana, AG Fadhlurrahman, MF Kurniawan, NRAS Aji
    Year: 2023
    Citation: Journal of Stomatology 76(2), 94-100
  • Effect of the Application of Curcumin (Curcuma longa) Oral Gel on Periodontal Inflammation in Patients with Type 2 Diabetes Mellitus
    Authors: NR Aji, VM Karina, OA Hafiyyah, K Murdiastuti, A Syaify
    Year: 2022
    Citation: Maj Kedokt Gig Indones 7(3), 160-164

Julio Jesús Garcia Coste | Biochemistry | Research Excellence Award

Published on by Global Scholar Awards

Mr. Julio Jesús Garcia Coste | Biochemistry | Research Excellence Award

Instituto Politécnico Nacional | Mexico

Mr. Julio Jesús Garcia Coste is an interdisciplinary researcher integrating software engineering, language education, and health sciences, with a strong foundation in computer science and over a decade of experience in software analysis and quality assurance. He has contributed to 6 scholarly works spanning bioinformatics, biostatistical modeling, and language pedagogy, reflecting diverse collaboration across computational and health research domains. His recent research focuses on immunometabolic profiling and gene regulation in metabolic disorders, demonstrating expertise in data-driven health analytics. By combining computational methods with public health research, he contributes to advancing predictive modeling, improving disease understanding, and supporting evidence-based decision-making in healthcare and education systems.

View Scopus Profile

Featured Publications


The signal in the extreme: A systematic outlier framework identifies discrete immunometabolic subtypes in human and cellular models


– Garcia-Coste, J. J., Aguayo-Cerón, K. A., Espinosa-Raya, J., García-Rivero, A. A., López-Leyva, C., Gutiérrez-Rojas, R. A., Vargas-De-León, C., & Romero-Nava, R. (2026), Medical Sciences, 14(1), 128


KLF14 and SREBF-1 binding site associations with orphan receptor promoters in metabolic syndrome


– Garcia-Coste, J. J., Villafaña-Rauda, S., Aguayo-Cerón, K. A., Vargas-De-León, C., & Romero-Nava, R. (2025), International Journal of Molecular Sciences, 26(7), 2849


Web-monitoring module for the Xilema Suria video surveillance system


– Espinosa Pérez, D. L., Sánchez Ramírez, E., Garcia Coste, J. J., & Cabrera Domínguez, Y. C. (2015), Proceedings of the 13th LACCEI Conference

Mahmoud Mansour | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

Prof. Mahmoud Mansour | Pharmacology | Best Researcher Award

Professor | King Saud bin Abdulaziz University for Health Sciences | Saudi Arabia

Dr. Mahmoud Ahmed Mansour is a biomedical researcher affiliated with King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia, with recognized expertise in biochemical toxicology, oxidative stress, pharmacology, and cancer biology. His research primarily focuses on the molecular mechanisms of hepatocarcinogenesis, proteasome inhibition, antioxidant defense systems, and cardiometabolic complications. Dr. Mansour has authored 40 peer-reviewed publications, accumulating over 1,879 citations, with an h-index of 18, reflecting sustained scientific impact and scholarly influence. His highly cited works explore the antineoplastic potential of proteasome inhibitors such as carfilzomib, as well as oxidative stress in metabolic and reproductive health conditions. He has collaborated with more than 50 international co-authors, demonstrating strong interdisciplinary and cross-institutional engagement. The societal relevance of his research lies in advancing therapeutic strategies for cancer prevention, metabolic disorders, and drug-induced toxicity, contributing to improved clinical understanding and translational biomedical outcomes at a global level.

Citation Metrics (Scopus)

1879
1400
900
400
0

Citations

1,879

Documents

40

h-index

18

Citations

Documents

h-index

View Google Scholar Profile View Scopus Profile View ORCID Profile

Featured Publications

Sibel Mataraci Karakas | Medical Biochemistry | Excellence in Research Award

Published on by Global Scholar Awards

Dr. Sibel Mataraci Karakas | Medical Biochemistry | Excellence in Research Award

Recep Tayyip Erdogan University | Turkey

Dr. Sibel Mataracı Karakaş is a researcher at Recep Tayyip Erdoğan University, Rize, Turkey, specializing in oral health sciences and periodontology. Her research centers on oxidative stress, alveolar bone loss, and inflammatory mechanisms, with strong emphasis on experimental and translational models relevant to dental diseases. She has authored multiple peer-reviewed publications that have received steady academic recognition, reflecting the quality and relevance of her work. Dr. Karakaş maintains active collaboration with national and international researchers, supporting interdisciplinary knowledge exchange. Her recent open-access research highlights the preventive role of bioactive compounds in periodontal conditions, contributing valuable insights for therapeutic development. Through evidence-based research, she supports improved preventive strategies, advances clinical understanding of periodontal disease, and contributes to the promotion of oral health and societal well-being at a broader level.

Citation Metrics (Scopus)

63
45
30
15
0

Citations

63

Documents

17

h-index

5

Citations

Documents

h-index

View Google Scholar Profile View Scopus Profile View ORCID Profile

Featured Publications

Xin Li | Sports Medicine | Best Researcher Award

Published on by Global Scholar Awards

Assoc. Prof. Dr. Xin Li | Sports Medicine | Best Researcher Award

Associate Professor| Tianjin Normal University | China

Dr. Xin Li is an accomplished scholar and educator specializing in clinical medicine and sports health sciences, currently serving as an Associate Professor at Tianjin Normal University since 2006. She obtained her Doctor of Medicine (MD) in Clinical Medicine from Tianjin Medical University in July 2006. Over nearly two decades of academic and research experience, Dr. Li has established herself as a leading expert at the intersection of clinical medicine, exercise science, and health management. Her teaching portfolio encompasses a range of courses in sports health, exercise rehabilitation, and health management, with a focus on integrating clinical case studies into theoretical instruction to enhance students’ practical competencies and professional insight. Dr. Li’s research primarily addresses exercise interventions for chronic diseases, sports injury prevention, and rehabilitation science, contributing to the growing evidence base linking physical activity with disease prevention and functional recovery. She has led and participated in numerous provincial and municipal research projects, achieving notable outcomes that have advanced the application of medical principles in sports health practice. To date, Dr. Li has published over ten academic papers in peer-reviewed core journals and international conferences, several of which have been widely cited and recognized within the academic community for their methodological rigor and clinical relevance. Her collaborative approach bridges disciplines such as physiology, public health, and kinesiology, fostering innovation and interdisciplinary integration in sports medicine research. Beyond academia, Dr. Li’s work holds significant societal impact, promoting the scientific development of exercise-based health strategies for chronic disease management and population well-being. Combining solid clinical expertise, pedagogical excellence, and a strong research record, Dr. Xin Li continues to contribute meaningfully to the advancement of sports health education and evidence-based medical practice in China and beyond.

Profile: Scopus 

Featured Publications

Li, X. (2025). The influence of initial and final character positional probabilities on the flexibility of position coding in two-character word identification. Acta Psychologica Sinica.

Dr. Xin Li’s work bridges clinical medicine and sports science, advancing evidence-based approaches to exercise intervention, chronic disease prevention, and rehabilitation. Her research and teaching contribute to improving public health outcomes and enhancing human performance, promoting global innovation in integrated medical and sports health education.

Probal Banerjee | Cancer Biology | Best Researcher Award

Published on by Global Scholar Awards

Prof. Probal Banerjee | Cancer Biology | Best Researcher Award

Professor| University of New York | United States

Dr. Probal Banerjee is a distinguished Professor of Chemistry and Coordinator of the Center for Developmental Neuroscience at The College of Staten Island, City University of New York, renowned for his pioneering contributions at the intersection of chemistry, neuroscience, and molecular pharmacology. Holding a Ph.D. in Bioorganic Chemistry from the Indian Institute of Science, Bangalore, and postdoctoral training at the University of Notre Dame and the University of Chicago, he has produced over 100 peer-reviewed publications that have advanced understanding of serotonergic signaling in brain development and innovative therapeutic strategies in cancer biology. His groundbreaking research on the 5-HT1A receptor’s role in neonatal hippocampal neurogenesis and on curcumin-based multi-target cancer therapies has redefined approaches to neurodevelopmental and oncological disorders, emphasizing immune modulation and translational impact. Dr. Banerjee’s recent studies on immune-friendly prodrugs and synergistic natural compounds reflect his commitment to safe, mechanism-driven, and sustainable therapeutic innovation. A frequent invited speaker at global scientific forums including Columbia University, NASA Ames, and the Indian Institute of Science, he collaborates internationally to bridge fundamental discovery with clinical relevance. Recognized with multiple honors such as the Brain Research Foundation Award and two Dolphin Awards for academic excellence and teaching, Dr. Banerjee continues to mentor emerging scientists and shape global biomedical research through his visionary work integrating molecular neuroscience, immunology, and drug development to enhance human health worldwide

Profiles: Scopus | ORCID

Featured Publications

Salutary effects of transdermal curcumin on multiple indices of health span in rodent models of normal aging and hypertension. Geroscience. 1 citation (2025).

Targeting sickle cell pathobiology and pain with novel transdermal curcumin. PNAS Nexus. 2 citations (2025).

Corrigendum: Dietary polyphenols, resveratrol and pterostilbene exhibit antitumor activity on an HPV E6-positive cervical cancer model: an in vitro and in vivo analysis. Frontiers in Oncology. 2 citations (2019).

Biocompatible anisole-nonlinear PEG core–shell nanogels for high loading capacity, excellent stability, and controlled release of curcumin. Gels. 8 citations (2023).

Why don’t the mutant cells that evade DNA repair cause cancer more frequently? Importance of the innate immune system in the tumor microenvironment. International Journal of Molecular Sciences. 4 citations (2023).

The G protein-coupled serotonin 1A receptor augments protein kinase Cε-mediated neurogenesis in neonatal mouse hippocampus—PKCε-mediated signaling in the early hippocampus. International Journal of Molecular Sciences. 2 citations (2022).

Dr. Probal Banerjee’s research bridges chemistry, neuroscience, and immunology to pioneer multi-target therapeutic strategies that combat cancer and neurodevelopmental disorders. His innovative work on curcumin-based immune therapies and serotonergic signaling mechanisms has advanced translational medicine, inspiring new, safer, and globally accessible approaches to human health and disease management.

Nermin Mutlu Bilgic | Gastroenterology | Best Researcher Award

Published on by Global Scholar Awards

Dr. Nermin Mutlu Bilgic | Gastroenterology | Best Researcher Award

Specialist | University of health sciences | Turkey

Dr. Nermin Mutlu Bilgic is a Gastroenterology Specialist at the University of Health Sciences Ümraniye Training and Research Hospital in Istanbul, Türkiye. She earned her Doctor of Medicine degree from Istanbul University Cerrahpaşa Faculty of Medicine in 2004, completed her residency in Internal Medicine at Maltepe University between 2007 and 2012, and obtained her subspecialty in Gastroenterology at Ümraniye Training and Research Hospital from 2015 to 2019. With over fifteen years of academic and clinical experience, Dr. Bilgiç specializes in hepatology, metabolic liver diseases, and inflammatory gastrointestinal disorders. She has served as Principal Investigator for international multicenter clinical trials evaluating the efficacy and safety of Saroglitazar Magnesium in patients with Primary Biliary Cholangitis and Nonalcoholic Steatohepatitis, reflecting her active contribution to global research in liver diseases. She has received certified training in Good Clinical Practice (GCP) from Roche/Genentech and the Global Health Training Centre, ensuring compliance with international ethical and regulatory standards. Dr. Bilgiç has authored and co-authored peer-reviewed publications and presented her work at several national and international gastroenterology and internal medicine conferences. Her professional focus integrates patient-centered clinical care with translational research aimed at improving therapeutic outcomes and understanding the mechanisms of chronic liver disease. She is also actively engaged in mentoring residents and fellows, contributing to medical education and the advancement of clinical research culture within her institution. Through her leadership in clinical trials, scientific collaborations, and commitment to ethical medical practice, Dr. Nermin Mutlu Bilgiç continues to make a meaningful impact on the advancement of gastroenterology and hepatology in both national and international contexts.

Profiles: Google Scholar | ORCID

Featured Publications

Kul, S., Caliskan, Z., Guvenc, T. S., Celik, F. B., Sarmis, A., Atici, A., Konal, O., Akıl, M., & Bilgiç, N. M. (2023). Gut microbiota-derived metabolite trimethylamine N-oxide and biomarkers of inflammation are linked to endothelial and coronary microvascular function in patients with …. Microvascular Research, 146, 104458 Cited by 31

Sayar, S., Aykut, H., Kaya, Ö., Kürbüz, K., Ak, Ç., Gökçen, P., Bilgiç, N. M., Adalı, G., & others. (2021). Bone mineral density screening and the frequency of osteopenia/osteoporosis in Turkish adult patients with celiac disease. The Turkish Journal of Gastroenterology, 32(7), 600–606 Cited by 13

Sayar, S., Kürbüz, K., Kahraman, R., Öztürk, O., Çalışkan, Z., Doğanay, H. L., Bilgiç, N. M., & others. (2020). Risk of hepatitis B reactivation during anti-TNF therapy: Evaluation of patients with past hepatitis B infection. The Turkish Journal of Gastroenterology, 31(7), 522–528 Cited by 13

Ozdil, K., Ozturk, O., Çalık, E. S., Akbas, E. S., Kanat, E., Caliskan, Z., Demirdag, H., Bilgiç, N. M., & others. (2016). Relationship between size of varices and platelet count/spleen size ratio in cirrhotic patients. Northern Clinics of Istanbul, 3(1), 46–50 Cited by 11

Adali, G., Bilgiç, N. M., Kalaman, A. E., Ozturk, O., & Ozdil, K. (2023). Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: A cross-sectional prospective study. Hepatology Forum, 4(3), 129–135 Cited by 8

 

Dr. Nermin Mutlu Bilgic work advances the understanding and management of chronic liver and metabolic diseases through evidence-based clinical research and international collaboration. Her contributions to hepatology and gastroenterology foster improved patient outcomes, support ethical research practices, and drive innovation in global liver health.

Qiushui Wang | Molecular Biology | Best Researcher Award

Published on by Global Scholar Awards

Assoc. Prof. Dr. Qiushui Wang | Molecular Biology | Best Researcher Award

Associate Professor| Institute of Analysis and Testing, Beijing Academy of Science and Technology (Beijing Center for Physical and Chemical Analysis) | China

Assoc. Prof. Dr. Qiushui Wang (born August 29, 1991) is a distinguished researcher specializing in biochemistry, molecular biology, and microbial natural products, currently serving as an Associate Research Fellow at the Beijing Center for Physical & Chemical Analysis (BCPCA), Beijing Academy of Science and Technology. She earned her Ph.D. in Biochemistry and Molecular Biology from the Institute of Microbiology, Chinese Academy of Sciences (IMCAS) in 2020 under the supervision of Prof. Zhang Lixin, with part of her doctoral research conducted at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) under Prof. Dr. Rolf Müller. Her academic journey began with a Bachelor’s degree in Pharmacy from Shandong University in 2014. Dr. Wang’s research focuses on microbial natural products, CRISPR/Cas9 gene editing in actinomycetes, microbial diversity, and antibiotic resistance mechanisms. She developed the innovative pQS gene-editing system, significantly improving gene-editing efficiency in rare actinomycetes and enabling new insights into the biosynthesis and yield enhancement of key bioactive compounds such as proxmicin and griselimycin. Her current work integrates multi-omics analysis, high-throughput sequencing, and microbial genomics to explore microbial community dynamics, antibiotic resistance genes, and probiotic strain development for aquaculture and crop health. Dr. Wang has authored several influential publications in journals such as Applied Microbiology and Biotechnology, Frontiers in Microbiology, and Environmental Science. Her research skills include microbial genome engineering, bioinformatics, multi-omics data analysis, natural product discovery, and analytical chemistry (HPLC-MS/MS). She has made remarkable contributions to understanding soil–microbe–crop interactions and antibiotic resistance in aquaculture environments. Recognized for her academic excellence and innovative research, Dr. Wang has received multiple institutional honors and continues to contribute significantly to advancing microbial biotechnology and sustainable environmental health. Her interdisciplinary expertise and leadership mark her as a rising figure in biochemical and microbial research.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate

Featured Publications

  • Wang, Q., Xie, F., Tong, Y., Habisch, R., Yang, B., Zhang, L., Müller, R., & Fu, C. (2020). Dual-function chromogenic screening-based CRISPR/Cas9 genome editing system for actinomycetes. Applied Microbiology and Biotechnology, 104(1), 225–239. Cited by: 27

  • Xie, F., Dai, S., Zhao, Y., Huang, P., Yu, S., Ren, B., Wang, Q., Ji, Z., Alterovitz, G., … (2020). Generation of fluorinated amychelin siderophores against Pseudomonas aeruginosa infections by a combination of genome mining and mutasynthesis. Cell Chemical Biology, 27(12), 1532–1543.e6. Cited by: 16

  • Fu, C., Xie, F., Hoffmann, J., Wang, Q., Bauer, A., Brönstrup, M., Mahmud, T., … (2019). Armeniaspirol antibiotic biosynthesis: Chlorination and oxidative dechlorination steps affording spiro[4.4]non-8-ene. ChemBioChem, 20(6), 764–769. Cited by: 13

  • Xie, F., Dai, S., Shen, J., Ren, B., Huang, P., Wang, Q., Liu, X., Zhang, B., Dai, H., … (2015). A new salicylate synthase AmS is identified for siderophores biosynthesis in Amycolatopsis methanolica 239T. Applied Microbiology and Biotechnology, 99(14), 5895–5905. Cited by: 10

  • Wang, Q., Zhou, X., Liu, Y., Han, Y., Zuo, J., Deng, J., Yuan, L., Gao, L., & Bai, W. (2023). Mixed oligosaccharides-induced changes in bacterial assembly during cucumber (Cucumis sativus L.) growth. Frontiers in Microbiology, 14, 1195096. Cited by: 9

Hywel Williams | Genomic Medicine | Best Researcher Award

Published on by Global Scholar Awards

Dr. Hywel Williams | Genomic Medicine | Best Researcher Award

Senior Lecturer | Cardiff University | United Kingdom

Dr. Hywel J. Williams is a distinguished academic and researcher currently serving as a Senior Lecturer in Bioinformatics: Genetic and Genomic Medicine in the Division of Cancer and Genetics, School of Medicine, Cardiff University, since 2019. He holds a Ph.D. in Genetics from Cardiff University (2001–2005), where his research focused on identifying schizophrenia susceptibility genes on chromosome 22 under the supervision of Prof. Sir Michael J. Owen. His earlier academic qualifications include a B.Sc. (Hons) in Genetics from Cardiff University (1994–1996) and an HND in Applied Biology from the University of Wales Institute Cardiff (1992–1994). Dr. Williams also earned recognition as an Associate Fellow of the Higher Education Academy in 2018. With over two decades of research experience, his career spans roles such as Senior Research Associate at UCL’s Great Ormond Street Institute of Child Health (2013–2018), and various research positions at Cardiff University from 1997 to 2012. His work integrates bioinformatics, genomics, and molecular genetics, with a primary focus on rare diseases, psychiatric genetics, and genomic medicine. His key contributions include joint first authorship of the landmark study “The 100,000 Genomes Pilot on Rare Disease Diagnosis in Healthcare” published in the New England Journal of Medicine (2021), and senior authorship in studies enhancing rapid pediatric sequencing and understanding of genetic disorders. Dr. Williams possesses advanced research skills in genomic data analysis, variant interpretation, computational biology, and multi-omic integration, contributing to the clinical translation of genome sequencing technologies. With an outstanding academic record—over 19,000 citations, an h-index of 56, and an i10-index of 101—he is recognized for his influential work in genomic research and data-driven healthcare. His career reflects a commitment to improving diagnostic accuracy and patient care through innovative bioinformatics approaches, making him a key contributor to the global advancement of precision and personalized medicine.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Purcell, S. M., Wray, N. R., Stone, J. L., Visscher, P. M., O’Donovan, M. C., Sullivan, P. F., Williams, H. J., et al. (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460(7256), 748–752. https://doi.org/10.1038/nature08185 Cited by: 5,521

  2. Schizophrenia Working Group of the Psychiatric Genomics Consortium. (2011). Genome-wide association study identifies five new schizophrenia loci. Nature Genetics, 43(10), 969–976. https://doi.org/10.1038/ng.940 Cited by: 2,110

  3. Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., et al. (2014). De novo mutations in schizophrenia implicate synaptic networks. Nature, 506(7487), 179–184. https://doi.org/10.1038/nature12929 Cited by: 1,920

  4. O’Donovan, M. C., Craddock, N., Norton, N., Williams, H., Peirce, T., Moskvina, V., et al. (2008). Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nature Genetics, 40(9), 1053–1055. https://doi.org/10.1038/ng.201 Cited by: 1,327

  5. 100,000 Genomes Project Pilot Investigators (including Williams, H. J.). (2021). 100,000 genomes pilot on rare-disease diagnosis in health care—preliminary report. New England Journal of Medicine, 385(20), 1868–1880. https://doi.org/10.1056/NEJMoa2035790 Cited by: 657

Valmir Rastely-Junior | Infectious Diseases | Young Scientist Award

Published on by Global Scholar Awards

Mr. Valmir Rastely-Junior | Infectious Diseases | Young Scientist Award

Universidade Federal da Bahia | Brazil

Mr. Valmir Rastely-Junior is a distinguished physician specializing in infectious diseases, pediatrics, and neuropediatrics, with an MD from the Federal University of Bahia (UFBA, 2015). He has accumulated extensive clinical and research experience, focusing on child health, congenital Zika syndrome, antimicrobial resistance, and public health inequities, integrating multidisciplinary care with evidence-based interventions. His professional trajectory includes work at Fiocruz Bahia on neurodevelopmental studies, epidemiologic surveillance, teratogen information services, and COVID-19 teleadvice programs. He has been instrumental in technology-driven initiatives such as Telecoronavírus (UFBA) and Artificial Intelligence as a Service for Combating COVID-19 (Rede CoVida/Cidacs Fiocruz), emphasizing the translation of research into practical, community-focused solutions. Mr. Rastely-Junior’s research interests center on infectious-disease–driven child health, neurodevelopmental outcomes in congenital infections, health disparities, and AI-supported clinical and epidemiological tools. He possesses strong research skills, including clinical study design, epidemiologic analysis, bibliometric synthesis, and international collaborative research, demonstrated through six peer-reviewed publications in Scopus and PubMed-indexed journals, three joint research projects, two conference presentations, and mentorship of research scholars. His work has earned eight awards and recognitions, including first-place honors at Fiocruz Bahia and an honorable mention in the International Balint Award/Ascona Prize, reflecting both scientific excellence and societal impact. Mr. Rastely-Junior is an active member of 16 professional bodies, contributing to editorial, review, and volunteer initiatives that promote knowledge dissemination and community engagement. In conclusion, his blend of clinical expertise, innovative research, international collaborations, and commitment to evidence-based public health positions him as a promising leader in global biomedical research, capable of advancing high-impact publications, AI-enabled solutions, and mentorship programs that enhance healthcare outcomes and scientific standards worldwide. 27 Citations | 3 Documents | 2 h-index.

Profiles: Google Scholar | Scopus | ORCID | LinkedIn

Featured Publications

  1. Aguilar Ticona, J. P., Nery Jr, N., Doss-Gollin, S., Gambrah, C., Lessa, M., … Rastely-Junior, V. N. (2021). Heterogeneous development of children with Congenital Zika Syndrome-associated microcephaly. PLoS One, 16(9), e0256444. https://doi.org/10.1371/journal.pone.0256444. Cited by: 26

  2. Nery Jr, N., Aguilar Ticona, J. P., Gambrah, C., Doss-Gollin, S., Aromolaran, A., … Rastely-Junior, V. N. (2021). Social determinants associated with Zika virus infection in pregnant women. PLoS Neglected Tropical Diseases, 15(7), e0009612. https://doi.org/10.1371/journal.pntd.0009612. Cited by: 14

  3. Aromolaran, A., Araujo, K., Ladines-Lim, J. B., Nery Jr, N., do Rosário, M. S., … Rastely-Junior, V. N. (2022). Unequal burden of Zika-associated microcephaly among populations with public and private healthcare in Salvador, Brazil. International Journal of Infectious Diseases, 120, 201–204. https://doi.org/10.1016/j.ijid.2022.06.021. Cited by: 6

  4. Mattos, A. M., Rastely-Junior, V. N., Pires, M. M., Aguilar, J. P., Lessa, M. S. A., Regis, C., … (2023). Predictors of neurodevelopment in microcephaly associated with congenital Zika Syndrome: A prospective study. Children, 10(12), 1831. https://doi.org/10.3390/children10121831. Cited by: 3

  5. Brito, L. B., Rastely-Junior, V. N., Browne, E. S., Nery Júnior, N. R. R., … (2016). Sinais e sintomas de zika-virus em gestantes internadas em um Hospital Público de referência da Bahia. Cited by: 2